Transient vs. prolonged histone hyperacetylation: Effects on colon cancer cell growth, differentiation, and apoptosis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 3 43-3, 2001, Pages

  Wu, James T ^a   Archer, Sonia Y ^a,b   Hinnebusch, Brian ^a   Meng, Shufen ^a   Hodin, Richard A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Alkaline phosphatase; Cyclin dependent kinase inhibitor; Sodium butyrate; Sodium potassium chlorine co transporter; Trichostatin A

Indexed keywords

ALKALINE PHOSPHATASE; BUTYRIC ACID; EPIDERMAL GROWTH FACTOR; HISTONE; MESSENGER RNA; PROPIDIUM IODIDE; PROTEIN P21; SOMATOMEDIN C; TRICHOSTATIN A;

ACETYLATION; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; COLON CANCER; CONTROLLED STUDY; DNA PROBE; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0035000305     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.3.g482     Document Type: Article

References (50)

1. Aaronson SA. Growth factor and cancer. Science 254: 1146-1153, 1991.
2. Allfrey V, Faulkner RM, and Mirsky AE. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 51: 786-794, 1964.
3. WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95: 6791-6796, 1998.
4. Archer SY, Meng S, Wu J, Johnson J, Tang R, and Hodin RA. Butyrate inhibits colon carcinoma cell growth through two distinct pathways. Surgery 124: 248-253, 1998.
5. Barnard JA and Warwick G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ 4: 495-501, 1993.
6. Boffa LC, Lupton JR, Mariani MR, Ceppi M, Newmark HL, Scalmati A, and Lipkin M. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 52: 5906-5912, 1992.
7. Candido EPM, Reeves R, and Davie J. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14: 105-113, 1978.
8. Chirgwin JM, Przybla AE, MacDonald RJ, and Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
9. Clausen MR. Butyrate and colorectal cancer in animals and humans. Eur J Cancer Prev 4: 483-490, 1995.
10. Cleveland DW, Lopata MA, McDonald RJ, Conan NJ, Rutter WJ, and Kirschner MW. Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes. Cell 20: 95-105, 1980.
11. Conteas CN, Desai TK, and Arlow FA. Relationship of hormones and growth factors to colon cancer. Gastroenterol Clin North Am 17: 761-772, 1998.
12. Cummings J, Binders HJ, and Soergel K. Short Chain Fatty Acids. Boston: Kluwer Academic, 1994, p. 135-147.
13. Czerniak B, Herz F, Westo RP, and Koss LG. Modification of H-ras oncogene p21 expression and cell cycle progression in the human colon cancer cell line HT-29. Cancer Res 47: 2826-2830, 1987.
14. Evers MB, Ko TC, Li J, and Thompson EA. Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 271: G722-G727, 1996.
15. Feinberg AP and Vogelstein BA. Technique for radiolabelling DNA restriction endonuclease fragment to high specific activity. Anal Biochem 132: 6-13, 1983.
16. Cartel AL, Serfas MS, Cartel M, Goufman E, Wu GS, El-Deiry WS, and Tyner AL. p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 cells intestinal cell line. Exp Cell Res 227: 171-181, 1996.
17. Hague A, Elder DJE, Hicks DJ, and Paraskeva C. Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 60: 400-406, 1995.
18. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, and Paraskeva C. Sodium butyrate induces apoptosis in the human colonic tumor cell line in a p53-independent pathway: implications for the possible role of dietary fiber in the prevention of large bowel cancer. Int J Cancer 55: 498-505, 1993.
19. Hebbes TR, Thorne TC, and Crane-Robinson C. A direct link between core histone acetylation to transcriptionally active chromatin. EMBO J 7: 1395-1402, 1988.
20. Heerdt BG, Houston MA, and Augenlicht LH. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell line. Cancer Res 54: 3288-3294, 1994.
21. Henthorn PS, Raducha M, Edwards YH, Weiss MJ, Slaughter C, Lafferty MA, and Harris H. Nucleotide and amino acid sequences of human intestinal alkaline phosphatase: close homology to placental alkaline phosphatase. Proc Natl Acad Sci USA 84: 1234-1238, 1987.
22. Hodin RA, Meng S, Archer S, and Tang R. Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell Growth Differ 7: 647-653, 1996.
23. Jacobs LR. Role of dietary factors in cell replication and colon cancer. Am J Clin Nutr 48: 775-779, 1988.
24. Leder A and Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemia cells. Cell 5: 319-322, 1975.
25. Lee DK, Chapkin RS, and Lupton JR. Dietary fat and fiber modulate colonic cell proliferation in an interactive site-specific manner. Nutr Cancer 20: 107-118, 1993.
26. Lee E, Furukubo T, Miyabe T, Yamauchi A, and Kariya K. Involvement of histone hyperacetylation in triggering DNA fragmentation of rat thymocytes undergoing apoptosis. FEBS Lett 395: 183-187, 1996.
27. Kip1. Surgery 124: 161-170, 1998.
28. Matthew JB, Hassan I, Meng S, Archer SY, Hrnjez BJ, and Hodin RA. Na-K-2Cl cotransporter gene expression and function during enterocyte differentiation. J Clin Invest 101: 2072-2079, 1998.
29. McBain JA, Eastman A, Nobel S, and Mueller GC. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol 53: 1357-1368, 1997.
30. McIntyre A, Gibson PR, and Young GP. Butyrate production from dietary fiber and protection against large bowel cancer in a rat model. Gut 34: 386-391, 1993.
31. Medina V, Afonso JJ, Alvarez-Arguelles H, Hernandez C, and Gonzalez F. Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. JPEN J Parenter Enteral Nutr 22: 14-17, 1998.
32. Medina V, Edmonds B, Young GP, James R, Appleton S, and Zalewski PD. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res 57: 3697-3707, 1997.
33. Metcalfe A and Streuli C. Epithelial apoptosis. Bioessays 19: 711-720, 1997.
34. Newmark HL, Lupton JR, and Young CW. Butyrate as a differentiating agent: pharmacokinetics, analogues and current status. Cancer Lett 78: 1-5, 1994.
35. Ogryzko W, Hirai TH, Russanova VR, Barbie DA, and Howard BH. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol Cell Biol 16: 5210-5218, 1996.
36. Potter JD, Slattery ML, Bostick RM, and Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev 15: 499-545, 1993.
37. Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, Shike M, Weissfeld J, Burt R, Cooper MR, Kikendall JW, and Cahill J. Lack of effect of a low fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 342: 1149-1155, 2000.
38. Sealy L and Chalkley R. DNA associated with hyperacetylated histone is preferentially digested by DNase I. Nucleic Acids Res 5: 1863-1876, 1978.
39. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, and El-Houseini ME. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389-3396, 1994.
40. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12: 599-606, 1998.
41. Trock B, Lanza E, and Greenwald P. Dietary fiber, vegetables, and colon cancer: critical review and meta-analysis of the epidemiological evidence. J Natl Cancer Inst 82: 605-661, 1990.
42. Van Munster IP and Nagengast FM. The role of carbohydrate fermentation in colon cancer prevention. Scand J Gastroenterol 28: 80-86, 1993.
43. Velazquez OC, Jabbar A, DeMatteo RP, and Rombeau JL. Butyrate inhibits seeding and growth of colorectal metastases to the liver in mice. Surgery 120: 440-447, 1996.
44. Waldman T, Kinzler KW, and Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55: 5187-5190, 1995.
45. Weil M, Jacobson MD, Coles HSR, Davies TJ, Gardner RL, Raff KD, and Raff MC. Constitutive expression of the machinery for programmed cell death. J Cell Biol 133: 1053-1059, 1996.
46. Whitehead RH, Young GP, and Bhathal PS. Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut 27: 1457-1463, 1986.
47. Yoshida K, Murohashi I, and Hirashima K. p53-independent induction of p21 (WAF1/CIP1) during differentiation of HL-60 cells by tumor necrosis factor α. Int J Hematol 65: 41-48, 1996.
48. Yoshida M and Beppu T. Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp Cell Res 177: 122-131, 1988.
49. Yoshida M, Kijima M, Akita M, and Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265: 17174-17179, 1990.
50. Yoshida M, Normura S, and Beppu T. Effects of trichostatin on differentiation of murine erythroleukemia cells. Cancer Res 47: 3688-3691, 1987.